ProQR Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.

About PRQR

ProQR Therapeutics NV is a clinical stage biopharmaceutical company. It is engaged in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases, such as Leber congenital amaurosis 10, Usher syndrome type 2, and autosomal dominant retinitis pigmentosa. 

CEO
Daniel Anton de Boer
CEODaniel Anton de Boer
Employees
182
Employees182
Headquarters
Leiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded
2012
Founded2012
Employees
182
Employees182

PRQR Key Statistics

Market cap
85.55M
Market cap85.55M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.40M
Average volume1.40M
High today
$1.28
High today$1.28
Low today
$1.13
Low today$1.13
Open price
$1.28
Open price$1.28
Volume
664.03K
Volume664.03K
52 Week high
$8.60
52 Week high$8.60
52 Week low
$0.53
52 Week low$0.53

Analyst ratings

56%

of 9 ratings
Buy
44.4%
Hold
55.6%
Sell
0%

PRQR Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.